Zurita, A J
Gagnon, R C
Liu, Y
Tran, H T
Figlin, R A
Hutson, T E
D'Amelio Jr, A M
Sternberg, C N
Pandite, L N
Heymach, J V
Article History
Received: 13 January 2017
Revised: 28 April 2017
Accepted: 7 June 2017
First Online: 6 July 2017
Competing interests
: AJ Zurita, HT Tran, RA Figlin, TE Hutson, and JV Heymach report no potential conflicts of interest. CN Sternberg reports having received personal fees from Novartis, GlaxoSmithKline, Astellas, Pfizer, and Bayer. RC Gagnon, Y Liu, AM D’Amelio Jr, and LN Pandite were employees of GlaxoSmithKline during the time of study conduct and initial manuscript development.